Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR

Neuropharmacology

Volumn 56, Issue 6-7, 2009, Pages 1060-1067

  Fricker, Anne Cécile ^a   Selina Mok, M H ^a   de la Flor, Raúl ^a   Shah, Ajit J ^a   Woolley, Marie ^a   Dawson, Lee A ^a   Kew, James N C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

mGluR2; mGluR3; N Acetylaspartylglutamate (NAAG); NMDAR

Indexed keywords

G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; GLUTAMATE CARBOXYPEPTIDASE II; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; N ACETYLASPARTYLGLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECOMBINANT RECEPTOR;

ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; DRUG MECHANISM; GRANULE CELL; HIPPOCAMPUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; CELL LINE; DIPEPTIDES; EXCITATORY POSTSYNAPTIC POTENTIALS; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HIPPOCAMPUS; HUMANS; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 67349089876     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.03.002     Document Type: Article

References (43)

1. Abi-Saab W.M., D'Souza D.C., Moghaddam B., and Krystal J.H. The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry 31 (1998) 104-109
2. Alexander G.M., and Godwin D.W. Presynaptic inhibition of corticothalamic feedback by metabotropic glutamate receptors. J. Neurophysiol. 94 (2005) 163-175
3. Anderson K.J., Monaghan D.T., Cangro C.B., Namboodiri M.A., Neale J.H., and Cotman C.W. Localization of N-acetylaspartylglutamate-like immunoreactivity in selected areas of the rat brain. Neurosci. Lett. 72 (1986) 14-20
4. Bergeron R., Coyle J.T., Tsai G., and Greene R.W. NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Neuropsychopharmacology 30 (2005) 7-16
5. Bergeron R., Imamura Y., Frangioni J.V., Greene R.W., and Coyle J.T. Endogenous N-acetylaspartylglutamate reduced NMDA receptor-dependent current neurotransmission in the CA1 area of the hippocampus. J. Neurochem. 100 (2007) 346-357
6. Cartmell J., Adam G., Chaboz S., Henningsen R., Kemp J.A., Klingelschmidt A., Metzler V., Monsma F., Schaffhauser H., Wichmann J., and Mutel V. Characterization of [3H]-(2S,2′R,3′R)-2-(2′,3′-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes. Br. J. Pharmacol. 123 (1998) 497-504
7. Cassidy M., and Neale J.H. N-Acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia. Neuropeptides 24 (1993) 271-278
8. Chopra, M., Yao, Y., Hampson, D.R., Johnson, E.C., 2007. Reassessment of agonist activity of NAAG on heterologously expressed mammalian mGluR3. SFN Poster, 679.5/F34.
9. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 205-237
10. Dascal N. Signalling via the G protein-activated K+ channels. Cell Signal 9 (1997) 551-573
11. Dawson L.A., Organ A.J., Winter P., Lacroix L.P., Shilliam C.S., Heidbreder C., and Shah A.J. Rapid high-throughput assay for the measurement of amino acids from microdialysates and brain tissue using monolithic C18-bonded reversed-phase columns. J. Chromatogr. B: Analyt Technol. Biomed. Life Sci. 807 (2004) 235-241
12. Gehl L.M., Saab O.H., Bzdega T., Wroblewska B., and Neale J.H. Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia. J. Neurochem. 90 (2004) 989-997
13. Ghose S., Weickert C.S., Colvin S.M., Coyle J.T., Herman M.M., Hyde T.M., and Kleinman J.E. Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia. Neuropsychopharmacology 29 (2004) 117-125
14. Guilarte T.R., Hammoud D.A., McGlothan J.L., Caffo B.S., Foss C.A., Kozikowski A.P., and Pomper M.G. Dysregulation of glutamate carboxypeptidase II in psychiatric disease. Schizophr. Res. 99 (2008) 324-332
15. Jentsch J.D., and Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20 (1999) 201-225
16. Kew J.N., Pflimlin M.C., Kemp J.A., and Mutel V. Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- mice. Neuropharmacology 43 (2002) 215-221
17. + current in neurones of the rat cerebellum. J. Physiol. 509 (1998) 347-354
18. Krystal J.H., Abi-Saab W., Perry E., D'Souza D.C., Liu N., Gueorguieva R., McDougall L., Hunsberger T., Belger A., Levine L., and Breier A. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl.) 179 (2005) 303-309
19. Lea IV P.M., Wroblewska B., Sarvey J.M., and Neale J.H. Beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor. J. Neurophysiol. 85 (2001) 1097-1106
20. Losi G., Vicini S., and Neale J. NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neurons. Neuropharmacology 46 (2004) 490-496
21. Mateo Z., and Porter J.T. Group II metabotropic glutamate receptors inhibit glutamate release at thalamocortical synapses in the developing somatosensory cortex. Neuroscience 146 (2007) 1062-1072
22. McNaughton B.L. Evidence for two physiologically distinct perforant pathways to the fascia dentata. Brain Res. 199 (1980) 1-19
23. Moffett J.R., Namboodiri M.A., and Neale J.H. Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J. Histochem. Cytochem. 41 (1993) 559-570
24. Moghaddam B. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology 174 (2004) 39-44
25. Olszewski R.T., Bukhari N., Zhou J., Kozikowski A.P., Wroblewski J.T., Shamimi-Noori S., Wroblewska B., Bzdega T., Vicini S., Barton F.B., and Neale J.H. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. J. Neurochem. 89 (2004) 876-885
26. Olszewski R.T., Wegorzewska M.M., Monteiro A.C., Krolikowski K.A., Zhou J., Kozikowski A.P., Long K., Mastropaolo J., Deutsch S.I., and Neale J.H. Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors. Biol. Psychiatry 63 (2008) 86-91
27. Patil S.T., Zhang L., Martenyi F., Lowe S.L., Jackson K.A., Andreev B.V., Avedisova A.S., Bardenstein L.M., Gurovich I.Y., Morozova M.A., Mosolov S.N., Neznanov N.G., Reznik A.M., Smulevich A.B., Tochilov V.A., Johnson B.G., Monn J.A., and Schoepp D.D. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat. Med. 13 (2007) 1102-1107
28. Robinson M.B., Blakely R.D., Couto R., and Coyle J.T. Hydrolysis of the brain dipeptide N-acetyl-l-aspartyl-l-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J. Biol. Chem. 262 (1987) 14498-14506
29. Schweitzer C., Kratzeisen C., Adam G., Lundstrom K., Malherbe P., Ohresser S., Stadler H., Wichmann J., Woltering T., and Mutel V. Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using semliki forest virus vectors. Neuropharmacology 39 (2000) 1700-1706
30. Shah A.J., Flor de la R., Atkins A., Dawson L.A., and Slone-Murphy J. Development and application of liquid chromatography/tandem mass spectrometric assay for measurement and application of N-acetylaspartate, N-acetylasparylglutamate and glutamate in brain slice superfusates and tissue extracts. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 876 (2008) 153-158
31. Shave E., Pliss L., Lawrance M.L., FitzGibbon T., Stastny F., and Balcar V.J. Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain. Neurochem. Int. 38 (2001) 53-62
32. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., and Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci. 17 (1997) 7503-7522
33. Slusher B.S., Vornov J.J., Thomas A.G., Hurn P.D., Harukuni I., Bhardwaj A., Traystman R.J., Robinson M.B., Britton P., Lu X.C., Tortella F.C., Wozniak K.M., Yudkoff M., Potter B.M., and Jackson P.F. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat. Med. 5 (1999) 1396-1402
34. Traynelis S.F., and Cull-Candy S.G. Proton inhibition of N-methyl-d-aspartate receptors in cerebellar neurons. Nature 345 (1990) 347-350
35. Trombley P.Q., and Westbrook G.L. Excitatory synaptic transmission in cultures of rat olfactory bulb. J. Neurophysiol. 64 (1990) 598-606
36. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., and Coyle J.T. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch. Gen. Psychiatry 52 (1995) 829-836
37. Westbrook G.L., Mayer M.L., Namboodiri M.A., and Neale J.H. High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture. J. Neurosci. 6 (1986) 3385-3392
38. Woolley M.L., Pemberton D.J., Bate S., Corti C., and Jones D.N. The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity. Psychopharmacol 196 (2008) 431-440
39. Wroblewska B., Wroblewska J.T., Saab O.H., and Neale J.H. N-Acetylaspartylglutamate inhibits forskolin-stimulated cyclic AMP levels via a metabotropic glutamate receptor in cultured cerebellar granule cells. J. Neurochem. 61 (1993) 943-948
40. Wroblewska B., Wroblewski J.T., Pshenichkin S., Surin A., Sullivan S.E., and Neale J.H. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 69 (1997) 174-181
41. Wroblewska B., Wegorzewska I.N., Bzdega T., Olszewski R.T., and Neale J.H. Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes. J. Neurochem. 96 (2006) 1071-1077
42. Wyllie D.J., Behe P., Nassar M., Schoepfer R., and Colquhoun D. Single-channel currents from recombinant NMDA NR1a/NR2D receptors expressed in Xenopus oocytes. Proc. Biol. Sci. 263 (1996) 1079-1086
43. Zollinger M., Amsler U., Do K.Q., Streit P., and Cuénod M. Release of N-acetylaspartylglutamate on depolarization of rat brain slices. J. Neurochem. 51 (1988) 1919-1923